CME/CE: Stroke Rounds: HbA1C Has Modest Impact on CVD Risk

Publication Date:
Thu, 10/01/2015
By: Alere Staff

SPONSORED BY

MedPage Today

American Heart Association

ACTIVE DATE

September 8, 2015 – September 8, 2017

CREDIT

Physicians: 0.25 AMA PRA Category 1 Credit(s) ™

DESCRIPTION

Adding hemoglobin A1C (HbA1c) to conventional cardiovascular risk assessment had only a modest effect on post-test, 10-year atherosclerotic cardiovascular disease (ASCVD) risk, researchers reported.

LINK

http://www.medpagetoday.com/Cardiology/Diabetes/53446